anti-mullerian hormone II receptor antagonist vaccine (Cleveland Clinic/Anixa Biosciences)

N/A

Report date: 2025/03/18 18:06:18

Base Information

Drug Nameanti-mullerian hormone II receptor antagonist vaccine (Cleveland Clinic/Anixa Biosciences)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionAnti-Mullerian hormone receptor II antagonists
TargetsAnti-Mullerian hormone receptor II
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Cleveland Clinic Foundation
China Registration ClassN/A

Develop Information

Active CompaniesInstitut National du CancerAnixa Biosciences IncThe Cleveland Clinic Foundation
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A